Democritus University of Thrace (DUTH)
Μελέτη μοριακών μηχανισμών αντικαρκινικής δράσης της σιλιμπινίνης (silibinin)
Abstract
dc:descriptionCancer prevention with the use of phytochemicals has attracted increased attention in recent years. Different phytochemicals have been associated with important chemopreventive potential against cancer including silibinin. Silibinin is the major active and most abundant ingredient of the silymarin complex derived from the seeds of the plant Silybum marianum (L) Gaertn. Silibinin (also silybin) that consists of a diastereoisomeric mixture of silybin A-B has been reported to possess strong chemopreventive and antineoplastic ability through pleiotropic mechanisms of action against different types of cancer, including prostate. The present study aimed to examine the molecular mechanisms by which silibinin exerts its anticancer activity in preclinical prostate cancer models, while it focused on its potential ability to interfere with and regulate major components of the epigenetic machinery, often deregulated and implicated in the pathogenesis of Prostate Cancer (PCa). Silibinin possessed significant antiproliferative activity against prostate cancer cells DU-145 and PC-3, mediated in part by inhibition of cell cycle in G1-G2/M phases, along with differential regulation of cyclins D and B, cyclin-dependent kinase inhibitors (CDKIs) p21 and p27 expression levels, and inhibition of their metastatic potential, as observed by immunoblot and wound healing assays. At an epigenetic level, silibinin reduced gene expression levels of PRC2 complex members (EZH2, EED, SUZ12), as evidenced by real-time PCR analysis. Specifically, the reduction of EZH2 levels was accompanied by increased levels of tri-methylated histone H3 at lysine 27 residues (H3K27me3), as evidenced by immunoblot and immunofluorescence analysis, a response that appeared to be a direct consequence of the reduced Akt and EZH2 phosphorylation levels in silibinin treatments. Furthermore, silibinin caused a modest increase in DNA methyltransferase activity, while reduced the expression levels of HOXA9 gene, a downstream target of EZH2, and decreased protein levels of histone deacetylases 1-2 (HDAC1-2). Interestingly, human epigenetic chromatin modification enzymes-focused DNA microarray and real-time quantitative reverse transcription-PCR (qRT-PCR) analyses revealed that silibinin altered differentially the expression of important epigenetic enzymes associated with gene expression regulation through modification of chromatin configuration, including members of the families of histone methyltransferases (SUV39H1), acetyltransferases (KAT6B), demethylases (KDM1) and deacetylases (HDAC1-3), along with enzymes that induce gene silencing via DNA methylation (MBD2) and regulate cell cycle progression (AURKA-B). Finally, SRB analysis revealed that silibinin enhanced the antiproliferative action of several epigenetic drugs, including 5-AZA cdR, SAHA and TSA, in a dose- and time-dependent manner in PCa cells. In conclusion, our study suggests, that the reported anticancer activity of silibinin in prostate cancer could be mediated, at least in part, through the disruption of central processes in chromatin conformation and alteration of key epigenetic enzymes regulating progression of the disease. Further studies are required to clarify in detail the precise molecular mechanism(s) that govern the pleiotropic action of silibinin against PCa towards this direction.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Anestopoulos, Ioannis
- Ανεστόπουλος, Ιωάννης
Subjects
dc:subject × 34- σιλιμπινίνη
- Σιλυμαρίνη
- Καρκίνος προστάτη
- Χημειοπρόληψη
- Φυσικά προϊόντα
- Αντικαρκινική δράση
- Επιγενετικές τροποποιήσεις
- μεθυλοτρανσφεράση EZH2
- H3Κ27me3
- Μεθυλίωση ιστόνων
- σύμπλοκο PRC2
- μεθυλοτρανσφεράσες DNA
- απακετυλάσες ιστονών
- silibinin
- Silymarin
- Prostate cancer
- Chemoprevention
- Natural compounds
- Anticancer activity
- Epigenetic modifications
- methyltransferase EZH2
- H3K27me3
- Histone methylation
- PRC2 complex
- DNA methyltransferases
- histone deacetylases
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42359